Successful companies need to incorporate real world evidence in clinical trials, post approval studies and in payer engagement programmes. Needless to say, this shift is causing monumental changes in how the industry operates, how the payers engage with them and how service providers support pharma.
This raises some important questions: What is value? What parts of our existing business model do we keep and what do we change? How do we get meaningful insights from the data being collected?
We put these questions to a number of thought leaders from industry and the payer community and collated their responses into the below ebook. Their views make compelling reading for anyone who is interested in getting the right drug, to the right patient at the right cost.
Download eBook here. (Source: totalbiopharma)